Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Konstantinos Paschidis
Observed name:
K. Paschidis
Institutions:
National and Kapodistrian University of Athens,
Academy of Athens,
Biomedical Research Foundation of the Academy of Athens
Observed institutions:
National and Kapodistrian University of Athens,
Academy of Athens,
Biomedical Research Foundation of the Academy of Athens
ORCID:
0009-0008-2552-6339
Observed ORCID:
0009-0008-2552-6339
OpenAlex ID:
A5080816211
Effect of light colour temperature and intensity on τhε behaviour of male C57CL/6J mice
2016
·
Aspasia Kapogiannatou
, Efthymios Paronis
, et al.
·
Applied Animal Behaviour Science
·
46
Methylation analysis of APC, AXIN2, DACT1, RASSF1A and MGMT gene promoters in non-small cell lung cancer
2022
·
Konstantinos Paschidis
, Alexandros Zougros
, et al.
·
Pathology - Research and Practice
·
11
Evidence for frequent concurrent DCUN1D1, FGFR1, BCL9 gene copy number amplification in squamous cell lung cancer
2021
·
Ilenia Chatziandreou
, Adriana Psaraki
, et al.
·
Pathology - Research and Practice
·
10
Growing male rats in individually ventilated and open-top cages.
2011
·
Nikolaos Kostomitsopoulos
, Ismene A Dontas
, et al.
·
PubMed
·
7
Lighting environment: What colour of light do male C57BL/6J prefer?
2018
·
Efthymios Paronis
, Aspasia Kapogiannatou
, et al.
·
Applied Animal Behaviour Science
·
6
Repurposing Amiodarone for Bladder Cancer Treatment
2025
·
Francisco J. Roa
, Maria Roubelakis
, et al.
·
Cancer Research Communications
·
2
Liver-Targeted Fetal MSC-Derived Extracellular Vesicles: A Therapeutic Approach in a Mouse Model of Acute Hepatic Failure
2025
·
Alexandra Stamatopoulou
, Maria Lefkaditi
, et al.
·
Research Square
PDF
Figure 3 from Repurposing Amiodarone for Bladder Cancer Treatment
2025
·
Francisco J. Roa
, Maria Roubelakis
, et al.
Supplementary Figure Legends from Repurposing Amiodarone for Bladder Cancer Treatment
2025
·
Francisco J. Roa
, Maria Roubelakis
, et al.
Data from Repurposing Amiodarone for Bladder Cancer Treatment
2025
·
Francisco J. Roa
, Maria Roubelakis
, et al.
Supplementary File 2 from Repurposing Amiodarone for Bladder Cancer Treatment
2025
·
Francisco J. Roa
, Maria Roubelakis
, et al.
Figure 5 from Repurposing Amiodarone for Bladder Cancer Treatment
2025
·
Francisco J. Roa
, Maria Roubelakis
, et al.
Figure 1 from Repurposing Amiodarone for Bladder Cancer Treatment
2025
·
Francisco J. Roa
, Maria Roubelakis
, et al.
Figure 2 from Repurposing Amiodarone for Bladder Cancer Treatment
2025
·
Francisco J. Roa
, Maria Roubelakis
, et al.
Figure 6 from Repurposing Amiodarone for Bladder Cancer Treatment
2025
·
Francisco J. Roa
, Maria Roubelakis
, et al.
Supplementary Figure 1 from Repurposing Amiodarone for Bladder Cancer Treatment
2025
·
Francisco J. Roa
, Maria Roubelakis
, et al.
Supplementary Figure 2 from Repurposing Amiodarone for Bladder Cancer Treatment
2025
·
Francisco J. Roa
, Maria Roubelakis
, et al.
Supplementary File 1 from Repurposing Amiodarone for Bladder Cancer Treatment
2025
·
Francisco J. Roa
, Maria Roubelakis
, et al.
Supplementary Table 2 from Repurposing Amiodarone for Bladder Cancer Treatment
2025
·
Francisco J. Roa
, Maria Roubelakis
, et al.
PDF
Figure 4 from Repurposing Amiodarone for Bladder Cancer Treatment
2025
·
Francisco J. Roa
, Maria Roubelakis
, et al.
Supplementary Table 1 from Repurposing Amiodarone for Bladder Cancer Treatment
2025
·
Francisco J. Roa
, Maria Roubelakis
, et al.
PDF
Amiodarone, an anti-arrhythmic drug, is a new repurposed drug for bladder cancer therapy
2024
·
F.J. Roa
, M.G. Roubelakis
, et al.
·
European Urology
From multi-omics integrated signatures to repurposed drugs for bladder cancer treatment: The case of cephaeline
2023
·
M.J. Hoffmann
, M. Makridakis
, et al.
·
European Urology Open Science
Show more works
View as search
Works count:
23
Citation count:
82
H-index:
5
I10-index:
3
Year
Topic
Type